Tay, Edgar
Paul, Biswajit
Sharp, Jason
Wang, Dennis
Chui, Angus Shing Fung
Hazra, Prakash Kumar
Santoso, Teguh
Albers, Bert
Diener, Hans-Christoph
Lewalter, Thorsten
Wong, Andrew
Article History
Received: 13 February 2020
Accepted: 14 April 2020
First Online: 26 June 2020
Compliance with ethical standards
:
: Edgar Tay is a speaker and proctor and received an educational grant from Boston Scientific. Jason Sharp is a proctor for Abbott and Boston Scientific. Dennis Wang is a proctor for Abbott. Angus Shing Fung Chui is a proctor for Boston Scientific. Bert Albers received a honorarium from Abbott for preparing this manuscript. In the last 3 years, Hans-Christoph Diener (HCD) received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from Abbott, Bayer Vital, BMS, Boehringer Ingelheim, Daiichi-Sankyo, Medtronic, Pfizer, Portola, Sanofi-Aventis, and WebMD Global. Financial support for research projects was provided by Boehringer Ingelheim. HCD received research grants from the German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, NIH, Bertelsmann Foundation, and Heinz-Nixdorf Foundation. HCD served as editor of Neurologie up2date, Info Neurologie & Psychiatrie, and Arzneimitteltherapie and is on the editorial board of Lancet Neurology. HCD chairs the Treatment Guidelines Committee of the German Society of Neurology and contributed to the EHRA and ESC guidelines for the treatment of AF. Thorsten Lewalter reported lectures and memberships of advisory boards with modest honoraria for Abbott, Boston Scientific, Lifetech, Bayer, Daiichi Sankyo, Pfizer, and Böhringer Ingelheim. Andrew Wong reports no disclosures or conflicts of interest.